Compare AANJANEYA LIFECARE with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PFIZER DR. DATSONS LABS/
PFIZER
 
P/E (TTM) x -10.9 45.3 - View Chart
P/BV x 0.2 7.5 2.2% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   PFIZER
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PFIZER
Mar-19
DR. DATSONS LABS/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1263,840 3.3%   
Low Rs312,080 1.5%   
Sales per share (Unadj.) Rs133.0455.0 29.2%  
Earnings per share (Unadj.) Rs0.293.8 0.2%  
Cash flow per share (Unadj.) Rs6.6109.4 6.0%  
Dividends per share (Unadj.) Rs022.50 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8658.2 19.6%  
Shares outstanding (eoy) m31.6645.75 69.2%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.66.5 9.0%   
Avg P/E ratio x516.131.6 1,635.2%  
P/CF ratio (eoy) x11.827.1 43.8%  
Price / Book Value ratio x0.64.5 13.5%  
Dividend payout %024.0 0.0%   
Avg Mkt Cap Rs m2,477135,420 1.8%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m563,238 1.7%   
Avg. sales/employee Rs ThNM7,911.4-  
Avg. wages/employee Rs ThNM1,230.9-  
Avg. net profit/employee Rs ThNM1,630.7-  
INCOME DATA
Net Sales Rs m4,21120,815 20.2%  
Other income Rs m791,674 4.7%   
Total revenues Rs m4,28922,489 19.1%   
Gross profit Rs m5695,712 10.0%  
Depreciation Rs m204714 28.6%   
Interest Rs m43073 590.1%   
Profit before tax Rs m136,599 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62,309 0.3%   
Profit after tax Rs m54,291 0.1%  
Gross profit margin %13.527.4 49.2%  
Effective tax rate %48.035.0 137.3%   
Net profit margin %0.120.6 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,85227,167 25.2%   
Current liabilities Rs m6,7118,917 75.3%   
Net working cap to sales %3.387.7 3.8%  
Current ratio x1.03.0 33.5%  
Inventory Days Days16168 237.2%  
Debtors Days Days31830 1,058.0%  
Net fixed assets Rs m3,6738,862 41.4%   
Share capital Rs m317458 69.2%   
"Free" reserves Rs m3,76129,656 12.7%   
Net worth Rs m4,07830,113 13.5%   
Long term debt Rs m1,67125 6,683.2%   
Total assets Rs m12,63339,400 32.1%  
Interest coverage x1.091.5 1.1%   
Debt to equity ratio x0.40 49,357.2%  
Sales to assets ratio x0.30.5 63.1%   
Return on assets %3.411.1 31.1%  
Return on equity %0.114.2 0.8%  
Return on capital %7.722.1 34.7%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m964428 225.1%   
Fx outflow Rs m607786 77.2%   
Net fx Rs m357-358 -99.7%   
CASH FLOW
From Operations Rs m1,345978 137.5%  
From Investments Rs m-2,256351 -642.3%  
From Financial Activity Rs m-1,200-1,099 109.2%  
Net Cashflow Rs m-2,111231 -914.5%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 1.4 4.9 27.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 23.7 397.0%  
Shareholders   20,807 85,207 24.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   BIOCON   CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  GLENMARK PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens above 50,000-Mark; Tata Motors & Bajaj Finance Top Gainers(09:30 am)

Asian share markets rose for the third straight session today, tracking gains in US peers. The Nikkei is trading up by 0.7% and the Hang Seng is trading up by 0.1%.

Related Views on News

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - TORRENT PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS